Business
Global report
Regulatory
Pharmacovigilance
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Companies
Contract manufacturing
Equipment
Outsourcing
Packaging
Supply chain
Technology Transfer
EIPG Newsletter
Technology & Production
Regulatory
Politics & Business
Focus on EU’s Countries
News from EIPG
Search
Who we are
How to use and read
Pharma World
Business
Global report
Regulatory
Pharmacovigilance
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Companies
Contract manufacturing
Equipment
Outsourcing
Packaging
Supply chain
Technology Transfer
EIPG Newsletter
Technology & Production
Regulatory
Politics & Business
Focus on EU’s Countries
News from EIPG
Home
Authors
Posts by Giuliana Miglierini
Giuliana Miglierini
79 POSTS
0 COMMENTS
Biosimilars: the strategic imperative to balance between the needs for innovation...
Giuliana Miglierini
-
15 May 2019
0
EMA’s vision on evidence by design to evaluate the added therapeutic...
Giuliana Miglierini
-
15 May 2019
0
How to address the choice of an API supplier
Giuliana Miglierini
-
15 May 2019
0
Greece: The National Chamber of Pharmacists
Giuliana Miglierini
-
15 May 2019
0
Switzerland: The new Swiss regulatory framework
Giuliana Miglierini
-
16 April 2019
0
Transparency, still a long road to reach the goal
Giuliana Miglierini
-
16 April 2019
0
The EURIPID Collaboration for pricing and reimbursement
Giuliana Miglierini
-
16 April 2019
0
Transforming Big Pharma’s model
Giuliana Miglierini
-
16 April 2019
0
EMA’s first guideline on medical devices integral to medicinal products
Giuliana Miglierini
-
21 March 2019
0
Belgium: Impact of the emergence of precisions medicines in clinical trials
Giuliana Miglierini
-
21 March 2019
0
1
2
3
...
8
Page 1 of 8
